Shield Therapeutics plc (AIM:STX)
London
· Delayed Price · Currency is GBP · Price in GBX 8.88
-0.16 (-1.77%)
Mar 6, 2026, 1:08 PM GMT
Shield Therapeutics Revenue
Shield Therapeutics had revenue of $21.45M USD in the half year ending June 30, 2025, with 472.99% growth. This brings the company's revenue in the last twelve months to $41.50M, up 93.23% year-over-year. In the year 2024, Shield Therapeutics had annual revenue of $32.18M with 145.93% growth.
Revenue (ttm)
$41.50M
Revenue Growth
+93.23%
P/S Ratio
3.19
Revenue / Employee
$658.65K
Employees
63
Market Cap
96.59M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.18M | 19.10M | 145.93% |
| Dec 31, 2023 | 13.09M | 7.59M | 137.95% |
| Dec 31, 2022 | 5.50M | 3.44M | 167.35% |
| Dec 31, 2021 | 2.06M | -12.12M | -85.50% |
| Dec 31, 2020 | 14.18M | 13.23M | 1,389.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Venture Life Group | 31.23M |
| ECO Animal Health Group | 85.81M |
| Animalcare Group | 81.07M |
| Provexis | 871.27K |
| Allergy Therapeutics | 55.04M |
| HUTCHMED (China) | 439.54M |
| N4 Pharma | 7.07K |
| Hikma Pharmaceuticals | 2.49B |
Shield Therapeutics News
- 5 years ago - OTC Markets Group Welcomes Shield Therapeutics PLC to OTCQX - PRNewsWire